Alphabet, Pfizer, Merck, Apple, Gilead Sciences, and more earnings are scheduled for the week between April 29 and May 3. Check out what to expect from the major earnings reports this week.
Alphabet Inc. (NASDAQ: GOOGL) will announce first-quarter earnings on Monday after the bell. Analysts expect earnings to fall by 20.80% to $10.56 per share while revenue to rise by 19.90% to $37.34 billion. The bottom line will be hurt by higher costs and expenses while the top line will be benefited by higher revenue from Google and advertising. The costs are likely to be associated with the Artificial Intelligence (A.I.) and machine learning as cloud segment could show healthy improvement.
General Electric (NYSE: GE) will report first-quarter results on Tuesday before the bell. Analysts predict earnings of $0.09 per share on revenue of $27.05 billion. The results will be impacted by the Power unit, which is likely to continue its lackluster performance hurt by industry-wide weakness. The company has been struggling to focus on core industrial operations by jettisoning other businesses, irrespective of their profit-making abilities.
Mastercard (NYSE: MA) is set to post first-quarter results on Tuesday. Analysts expect earnings to jump by 10.70% to $1.66 per share helped by broad-based growth across each of its regions. Revenue is anticipated to rise 7.80% to $3.86 billion with growths in gross dollar volume, purchase volume and switched transactions. The company is likely to announce higher Mastercard and Maestro-branded cards issuance for the quarter.
Mcdonald’s Corp. (NYSE: MCD) will post Q1 results on Tuesday. Analysts project the company to report earnings of $1.76 per share on revenue of $4.93 billion. The results will be hurt by higher operating costs and expenses as well as an increase in provision for income taxes. The top line is likely to be impacted by the strategic refranchising initiative. However, comparable sales could increase positive comps across all segments.
BP Plc (NYSE: BP) will announce Q1 earnings on Tuesday. Earnings are expected to decline by 14.10% to $0.67 per share and revenue is likely to fall by 12.40% to $60.6 billion. The British oil company is likely to be hurt by lower liquids and gas realizations, weak gas marketing and trading results and a fall in production. There remained macroeconomic concerns that could hurt the company’s results. Those include uncertainties surrounding Brexit and trade war between US and China.
General Motors Company (NYSE: GM) is set to post first-quarter results on Tuesday. Analysts project earnings to fall 22.40% to $1.11 per share due to restructuring charges as well as higher costs and expenses. Revenue is predicted to decline 2.50% to $35.21 billion as the ongoing slump in the demand for passenger vehicles weighed on the quarterly performance. Vehicle deliveries declined year-over-year in the US as buyers continued to dump conventional cars in favor of SUVs and trucks.
Pfizer Inc. (NYSE: PFE) will report Q1 earnings on Tuesday. Analysts see a profit of $0.75 per share on revenue of $12.99 billion. The results will be hurt by weak results from its Innovative Health segment and Essential Health segment. The company is likely to be busy with important clinical data readouts across its early-, mid- and late-stage pipeline. This is expected to hurt the quarterly results as more costs are incurred due to clinical trials.
Merck & Co. Inc. (NYSE: MRK) could post Q1 results on Tuesday. Earnings are anticipated to be in line with last year at $1.05 per share and revenue is likely to rise 4.40% to $10.48 billion. The company’s results are anticipated to be driven by higher top-line growth and management of costs and expenses. The strength in oncology and vaccines could drive the Pharmaceutical segment. The higher sales of companion animal and livestock products along with newly launched products could drive the Animal Health segment.
Apple Inc. (NASDAQ: AAPL) will report Q2 earnings on Tuesday after the bell. Analysts see a profit of $2.36 per share on revenue of $57.44 billion. The results will be hurt by a further sharp decline in the sales of the iPhone and iPad. The sales of Apple’s flagship product has been on a downward spiral for the past several months. In order to tackle faltering sales, the company reduced its prices of iPhones in China.
Also read: A Electric motorcycle ride to profitability for Tesla
As Advanced Micro Devices Inc. (NASDAQ: AMD) announces Q1 results on Tuesday, analysts expect earnings of $0.05 per share on revenue of $1.26 billion. The results will be hurt by the underperformance of the Computing and Graphics segment caused by lower Ryzen processors sales. The company had expected continued softness in the graphics channel and seasonality across the business. The graphics sales will be impacted by the excess channel inventory, the absence of blockchain-related GPU revenue and lower memory sales.
CVS Health (NYSE: CVS) will announce first-quarter earnings on Wednesday before the bell. Analysts expect earnings to rise 1.40% to $1.5 per share and revenue to jump 32.30% to $60.47 billion. The top line will be benefited by the increases in pharmacy network claims and prescription volumes in the Pharmacy Services and Retail/LTC segments, as well as the addition of Aetna. An increase in costs and expenses are likely to narrow down the top line growth
Qualcomm Inc. (NASDAQ: QCOM) will report second-quarter results on Wednesday after the bell. Analysts predict earnings of $0.71 per share on revenue of $4.8 billion. The results will be negatively impacted by its dispute with Apple and its contract manufacturers as well as a charge related to the tax act. The company has faced a variety of fairly unique headwinds regarding legal threats to its high-margin QTL segment and increasing competition in the hardware space.
DowDuPont Inc. (NYSE: DWDP) is set to post first-quarter results on Thursday before the bell. Analysts expect earnings to drop by 25% to $0.84 per share due to an increase in costs and expenses along with lower top line growth. Revenue is anticipated to fall 7.50% to $19.9 billion with declines in price and volume offset currency. Global economic expansion is likely to continue in 2019 at a moderately slower pace than 2018.
Activision Blizzard (NASDAQ: ATVI) will post Q1 results on Thursday after the bell. Analysts project the company to report earnings of $0.26 per share on revenue of $1.25 billion. The results will be hurt by higher costs and expenses as well as an increase in income tax expense. The company will incur a restructuring charge related to the integration of its global and regional sales and go-to-market, partnerships, and sponsorships capabilities.
Gilead Sciences (NASDAQ: GILD) will announce Q1 earnings on Thursday. Earnings are expected to jump 8.80% to $1.61 per share and revenue is likely to increase 4.50% to $5.31 billion. The results will include an unfavorable impact from impairment and a non-cash tax charge related to intangible assets acquired from Kite Pharma Inc. The results will be benefited by higher product sales across the globe and an increase in HIV product sales.